FGF2 and pulmonary emphysema: Intranasal FGF-2 administration had a protective effect on emphysema: (1) a decline in the number of inflammatory cells, especially macrophages and lymphocytes, in BAL fluid; and (2) a decline in alveolar destruction and a regenerative effect in emphysematous mice.